Medidata will be expanding its long-standing partnership with Sanofi, now leveraging Medidata Patient, Data, and Study Experiences within the collaboration. The ecosystem of tools aims to address ...

Revisit top insights from SCOPE Summit 2025, where industry leaders explored how artificial intelligence is reshaping trial ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD ...

Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...

A clinical trial demonstrated that adding the Galleri multi-cancer early detection blood test to standard screening methods ...

New CMO, EVP Operations and SVP Clinical Solutions bring track records of scalable ... and validated models to complement expert clinician review, accelerating signal detection and supporting ...

A light-activated graphene and black phosphorus biosensor detects Alzheimer's biomarkers in blood at zeptomole sensitivity, ...

How are clinicians to preserve core clinical skills in an era of algorithmic assistance? As artificial intelligence (AI) ...

Cancer will claim an estimated 618,000 lives in the U.S. in 2025, according to the American Cancer Society. Yet, despite advances in treatment, most ...

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...